TYRA
Tyra Biosciences, Inc.
Latest Form 4:Sale$529KbyKAPLAN GILLA (Director) · filed Mar 27, 2026
Tyra Biosciences, Inc. (TYRA) has 12 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: May 7, 2026.
The most active filer is Chief Discovery Officer Bensen Daniel with 3 filings. Insiders have net sold $1.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Todd Harris
- Employees:87
- HQ:Carlsbad, CA, US
- IPO:2021-09-15
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$1.9B
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
KAPLAN GILLAFirst filing | Director | Sale | 14,295 | $529K | Mar 27 | SEC ↗ |
| Chief Discovery Officer | Sale | 8,000 | $263K | Feb 13 | SEC ↗ | |
| Chief Discovery Officer | Sale | 8,000 | $228K | Jan 20 | SEC ↗ | |
MORE ROBERT JFirst filing | Director | Sale | 10,000 | $250K | Dec 19 | SEC ↗ |
Bensen DanielFirst filing | Chief Discovery Officer | Sale | 8,000 | $181K | Dec 16 | SEC ↗ |
Related companies
Tyra Biosciences, Inc. is in the Healthcare sector.